RPS24P16

Across TCGA pan-cancer cohorts, RPS24P16 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPS24P16 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RPS24P16 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS24P16 expression acts as an unfavorable survival marker, although some lineages such as KICH and BRCA show a favorable association.

BLCA, ESCA, and KICH are the cancer types where RPS24P16 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	II,III,IV	0.424	0.546	.014	48	view →
ESCA	DFS	Tertile	All	0.273	0.517	.002	31	view →
KICH	OS	Median	II,III,IV	1.000	0.687	.007	29	view →
MESO	OS	Tertile	All	0.402	0.608	.010	25	view →
LUSC	DFS	Median	IV	0.134	0.827	.014	24	view →
BRCA	OS	Median	III,IV	0.881	0.783	.017	21	view →
CHOL	DFS	Median	III,IV	0.647	0.127	.006	18	view →
SKCM	OS	Tertile	III,IV	0.890	0.777	.011	16	view →
COAD	DFS	Quartile	All	0.797	0.489	.010	13	view →
UVM	OS	Tertile	All	1.000	0.754	.020	12	view →
READ	OS	Median	IV	0.455	0.824	.005	11	view →
LIHC	OS	Tertile	III,IV	0.283	0.588	.006	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RPS24P16–BLCA (DFS)

Open the BLCA breakdown →